Yu, Paul B.

ACVR1 R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

Hatsell, S. J., Idone, V., Wolken, D. M. A., Huang, L., Kim, H. J., Wang, L., Wen, X., Nannuru, K. C., Jimenez, J., Xie, L., et al. (2015) · Science Translational Medicine

Heterotopic Ossification and Related ConditionsBone Tumor Diagnosis and Treatments

Cited by 446

Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells

Boergermann, J. H., Kopf, J., Yu, P. B., & Knaus, P. (2010) · The International Journal of Biochemistry & Cell Biology

TGF-β signaling in diseasesDevelopmental Biology and Gene Regulation

Cited by 175

Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation

Steinbicker, A. U., Sachidanandan, C., Vonner, A. J., Yusuf, R. Z., Deng, D. Y., Lai, C. S., Rauwerdink, K. M., Winn, J. C., Saez, B., Cook, C. M., et al. (2011) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 173

Oral administration of a bone morphogenetic protein type I receptor inhibitor prevents the development of anemia of inflammation

Mayeur, C., Kolodziej, S. A., Wang, A., Xu, X., Lee, A., Yu, P. B., Shen, J., Bloch, K. D., & Bloch, D. B. (2015) · Haematologica

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 38

Hepcidin regulation by BMP signaling in macrophages is lipopolysaccharide dependent

Wu, X., Yung, L.-M., Cheng, W.-H., Yu, P. B., Babitt, J. L., Lin, H. Y., & Xia, Y. (2012) · PLoS ONE

Iron Metabolism and DisordersTGF-β signaling in diseases

Cited by 34